Hourly oral sodium chloride for the rapid and predictable treatment of hyponatremia

Eric Kerns, Shweta Patel, David Cohen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hypertonic NaCl is first-line therapy for acute, severe and symptomatic hyponatremia; however, its use is often restricted to the intensive care unit (ICU). A 35-year-old female inpatient with an optic chiasm glioma and ventriculoperitoneal shunt for hydrocephalus developed acute hyponatremia (sodium 122 mEq/L) perhaps coinciding with haloperidol treatment. The sum of her urinary sodium and potassium concentrations was markedly hypertonic vis-à-vis plasma; it was inferred that serum sodium concentration would continue to fall even in the complete absence of fluid intake. Intravenous (IV) 3% NaCl was recommended; however, a city-wide public health emergency precluded her transfer to the ICU. She was treated with hourly oral NaCl tablets in a dose calculated to deliver the equivalent of 0.5 mL/kg/h of 3% NaCl with an objective of increasing the serum sodium concentration by 6 mEq/L. She experienced a graded and predictable increase in serum sodium concentration. A slight overshoot to 129 mEq/L was rapidly corrected with 0.25 l of D5W, and she stabilized at 127 mEq/L. We conclude that hourly oral NaCl, in conjunction with careful monitoring of the serum sodium concentration, may provide an attractive alternative to IV 3% NaCl for selected patients with severe hyponatremia.

Original languageEnglish (US)
Pages (from-to)397-401
Number of pages5
JournalClinical Nephrology
Volume82
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Hyponatremia
Sodium Chloride
Sodium
Serum
Intensive Care Units
Therapeutics
Optic Nerve Glioma
Optic Chiasm
Ventriculoperitoneal Shunt
Haloperidol
Hydrocephalus
Tablets
Inpatients
Potassium
Emergencies
Public Health

Keywords

  • Arginine vasopressin
  • Hyponatremia
  • Osmoregulation
  • Sodium chloride

ASJC Scopus subject areas

  • Nephrology

Cite this

Hourly oral sodium chloride for the rapid and predictable treatment of hyponatremia. / Kerns, Eric; Patel, Shweta; Cohen, David.

In: Clinical Nephrology, Vol. 82, No. 6, 2014, p. 397-401.

Research output: Contribution to journalArticle

@article{4c9a4501bce94e97b3a021e60af21b22,
title = "Hourly oral sodium chloride for the rapid and predictable treatment of hyponatremia",
abstract = "Hypertonic NaCl is first-line therapy for acute, severe and symptomatic hyponatremia; however, its use is often restricted to the intensive care unit (ICU). A 35-year-old female inpatient with an optic chiasm glioma and ventriculoperitoneal shunt for hydrocephalus developed acute hyponatremia (sodium 122 mEq/L) perhaps coinciding with haloperidol treatment. The sum of her urinary sodium and potassium concentrations was markedly hypertonic vis-{\`a}-vis plasma; it was inferred that serum sodium concentration would continue to fall even in the complete absence of fluid intake. Intravenous (IV) 3{\%} NaCl was recommended; however, a city-wide public health emergency precluded her transfer to the ICU. She was treated with hourly oral NaCl tablets in a dose calculated to deliver the equivalent of 0.5 mL/kg/h of 3{\%} NaCl with an objective of increasing the serum sodium concentration by 6 mEq/L. She experienced a graded and predictable increase in serum sodium concentration. A slight overshoot to 129 mEq/L was rapidly corrected with 0.25 l of D5W, and she stabilized at 127 mEq/L. We conclude that hourly oral NaCl, in conjunction with careful monitoring of the serum sodium concentration, may provide an attractive alternative to IV 3{\%} NaCl for selected patients with severe hyponatremia.",
keywords = "Arginine vasopressin, Hyponatremia, Osmoregulation, Sodium chloride",
author = "Eric Kerns and Shweta Patel and David Cohen",
year = "2014",
doi = "10.5414/CN108014",
language = "English (US)",
volume = "82",
pages = "397--401",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "6",

}

TY - JOUR

T1 - Hourly oral sodium chloride for the rapid and predictable treatment of hyponatremia

AU - Kerns, Eric

AU - Patel, Shweta

AU - Cohen, David

PY - 2014

Y1 - 2014

N2 - Hypertonic NaCl is first-line therapy for acute, severe and symptomatic hyponatremia; however, its use is often restricted to the intensive care unit (ICU). A 35-year-old female inpatient with an optic chiasm glioma and ventriculoperitoneal shunt for hydrocephalus developed acute hyponatremia (sodium 122 mEq/L) perhaps coinciding with haloperidol treatment. The sum of her urinary sodium and potassium concentrations was markedly hypertonic vis-à-vis plasma; it was inferred that serum sodium concentration would continue to fall even in the complete absence of fluid intake. Intravenous (IV) 3% NaCl was recommended; however, a city-wide public health emergency precluded her transfer to the ICU. She was treated with hourly oral NaCl tablets in a dose calculated to deliver the equivalent of 0.5 mL/kg/h of 3% NaCl with an objective of increasing the serum sodium concentration by 6 mEq/L. She experienced a graded and predictable increase in serum sodium concentration. A slight overshoot to 129 mEq/L was rapidly corrected with 0.25 l of D5W, and she stabilized at 127 mEq/L. We conclude that hourly oral NaCl, in conjunction with careful monitoring of the serum sodium concentration, may provide an attractive alternative to IV 3% NaCl for selected patients with severe hyponatremia.

AB - Hypertonic NaCl is first-line therapy for acute, severe and symptomatic hyponatremia; however, its use is often restricted to the intensive care unit (ICU). A 35-year-old female inpatient with an optic chiasm glioma and ventriculoperitoneal shunt for hydrocephalus developed acute hyponatremia (sodium 122 mEq/L) perhaps coinciding with haloperidol treatment. The sum of her urinary sodium and potassium concentrations was markedly hypertonic vis-à-vis plasma; it was inferred that serum sodium concentration would continue to fall even in the complete absence of fluid intake. Intravenous (IV) 3% NaCl was recommended; however, a city-wide public health emergency precluded her transfer to the ICU. She was treated with hourly oral NaCl tablets in a dose calculated to deliver the equivalent of 0.5 mL/kg/h of 3% NaCl with an objective of increasing the serum sodium concentration by 6 mEq/L. She experienced a graded and predictable increase in serum sodium concentration. A slight overshoot to 129 mEq/L was rapidly corrected with 0.25 l of D5W, and she stabilized at 127 mEq/L. We conclude that hourly oral NaCl, in conjunction with careful monitoring of the serum sodium concentration, may provide an attractive alternative to IV 3% NaCl for selected patients with severe hyponatremia.

KW - Arginine vasopressin

KW - Hyponatremia

KW - Osmoregulation

KW - Sodium chloride

UR - http://www.scopus.com/inward/record.url?scp=84920267717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920267717&partnerID=8YFLogxK

U2 - 10.5414/CN108014

DO - 10.5414/CN108014

M3 - Article

C2 - 23816479

AN - SCOPUS:84920267717

VL - 82

SP - 397

EP - 401

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 6

ER -